(Q39673228)

13 September 2017

title

Hepatoma-derived growth factor promotes the resistance to anti-tumor effects of nordihydroguaiaretic acid in colorectal cancer cells (English)

1 reference

13 September 2017

1 reference

1 reference

Fei Liao

1

1 reference

13 September 2017

Meng Liu

2

1 reference

13 September 2017

Li Lv

3

1 reference

13 September 2017

Weiguo Dong

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 August 2010

1 reference

13 September 2017

25 October 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20674562

full work available at URL

14 June 2024

https://api.elsevier.com/content/article/PII:S0014299910007302?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

https://api.elsevier.com/content/article/PII:S0014299910007302?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

European Journal of Pharmacology

14 June 2024

published in

1 reference

13 September 2017

volume

645

1 reference

13 September 2017

issue

1-3

1 reference

13 September 2017

page(s)

55-62

1 reference

Nordihydroguairetic acid is a potent inhibitor of ferric-nitrilotriacetate-mediated hepatic and renal toxicity, and renal tumour promotion, in mice.

13 September 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Mechanisms of caspase activation

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Effects of a novel synthetic retinoid on malignant glioma in vitro: inhibition of cell proliferation, induction of apoptosis and differentiation.

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Lipoxygenase inhibition induced apoptosis, morphological changes, and carbonic anhydrase expression in human pancreatic cancer cells

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Mitochondria as therapeutic targets for cancer chemotherapy

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Synthetic retinoid CD437 induces mitochondria-mediated apoptosis in hepatocellular carcinoma cells

14 June 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Naturally occurring lignans efficiently induce apoptosis in colorectal tumor cells

14 June 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Nordihydroguaiaretic acid, an antioxidant, inhibits transforming growth factor-beta activity through the inhibition of Smad signaling pathway.

14 June 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Hepatoma-derived growth factor involved in the carcinogenesis of gastric epithelial cells through promotion of cell proliferation by Erk1/2 activation

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Lipoxygenase inhibitors prevent lung carcinogenesis and inhibit non-small cell lung cancer growth

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Partial purification and characterization of human hepatoma-derived growth factor

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Inhibition of N-linked glycosylation by tunicamycin enhances sensitivity to cisplatin in human head-and-neck carcinoma cells

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Global cancer statistics, 2002

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Spinal administration of lipoxygenase inhibitors suppresses behavioural and neurochemical manifestations of naloxone-precipitated opioid withdrawal

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Downregulation of hepatoma-derived growth factor activates the Bad-mediated apoptotic pathway in human cancer cells

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma.

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

Down-regulation of hepatoma-derived growth factor inhibits anchorage-independent growth and invasion of non-small cell lung cancer cells

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.EJPHAR.2010.07.033

14 June 2024

Identifiers

1 reference

13 September 2017

1 reference